Hunan Jiudian Pharmaceutical Co (SZSE:300705) Total Stockholders Equity : ¥2,649 Mil (As of Mar. 2025)

View and export this data going back to 2017. Start your Free Trial

What is Hunan Jiudian Pharmaceutical Co Total Stockholders Equity?

Hunan Jiudian Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Mar. 2025 was ¥2,649 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hunan Jiudian Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 was ¥5.34. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hunan Jiudian Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 was 0.14.

Hunan Jiudian Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Hunan Jiudian Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Jiudian Pharmaceutical Co Total Stockholders Equity Chart

Hunan Jiudian Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Stockholders Equity

Get a 7-Day Free Trial

835.68

1,099.34

1,552.62

1,973.27

2,526.73

Hunan Jiudian Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Stockholders Equity	Get a 7-Day Free Trial															2,106.82	2,178.28	2,383.00	2,526.73	2,649.36

Hunan Jiudian Pharmaceutical Co (SZSE:300705) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hunan Jiudian Pharmaceutical Co's Book Value per Share for the quarter that ended in Mar. 2025 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2649.362	-	0)	/	496.197
	=	5.34

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hunan Jiudian Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Mar. 2025 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(10.19	+	351.843)	/	2649.362
	=	0.14

Hunan Jiudian Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hunan Jiudian Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hunan Jiudian Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Jiudian Pharmaceutical Co Ltd (SZSE:300705) » Definitions » Total Stockholders Equity

Traded in Other Exchanges

N/A

Address

No.1 Health Avenue, Hunan Liuyang Bio Pharmaceutical Park, Hunan, Changsha, CHN, 410329

Website

http://www.jiudianph.com

Hunan Jiudian Pharmaceutical Co Ltd is a China-based pharmaceutical company specializing in research and development, manufacturing of pharmaceutical products, solid and liquid oral preparations and herbal extract products. It manufactures dirithromycin, levodropropizine and levocetirizine hydrochloride in China. The group's products include active pharmaceutical ingredients, herbal extracts, intermediaries, excipients and finished products.

Executives

Zhu Zhi Hong	Director
Duan Bin	Supervisors
Liang Sheng Hua	Supervisors
Zheng Xia Hui	Directors, executives
Duan Li Xin	Director
Zhu Zhi Yun	Director
Xiong Ying	Executives
Li Min	Secretary Dong
Fan Peng Yun	Executives

Hunan Jiudian Pharmaceutical Co Headlines

No Headlines